Overview
Matthew Hearn practices practicing medicine in Ottawa, Canada.
His clinical expertise encompasses Carotid Artery Disease, Parathyroid Cancer, Parathyroid Adenoma, and Glossectomy.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Matthew Hearn
Is Matthew Hearn a top-rated expert for Glossectomy?
MediFind is an objective health platform that identifies experts based on real-world data. Matthew Hearn is classified as an Experienced expert for Glossectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Matthew Hearn participate in research or clinical trials?
Yes. Matthew Hearn has published 9 articles and abstracts on conditions like Glossectomy. You can view a list of Matthew Hearn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Carotid Artery DiseaseMr. Hearn isExperienced. Learn about Carotid Artery Disease.
- GlossectomyMr. Hearn isExperienced. Learn about Glossectomy.
- Parathyroid AdenomaMr. Hearn isExperienced. Learn about Parathyroid Adenoma.
- Parathyroid CancerMr. Hearn isExperienced. Learn about Parathyroid Cancer.